Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Thrombin inhibitors in development at Lilly

Jan. 4, 1999

12-HETE inhibitor suppresses coronary thrombosis in dog model

Jan. 4, 1999

Warner-Lambert and BioChem Therapeutic seek potent and selective thrombin inhibitors

Dec. 30, 1998

Broader indication for Agrylin approved by FDA

Dec. 22, 1998

Orally bioavailable serine protease inhibitors for thrombotic disorders designed at Akzo

Dec. 22, 1998

Pharmacia & Upjohn to copromote Pletal tablets with Otsuka

Dec. 21, 1998

Corvas/Schering-Plough oral anticoagulant alliance extended

Dec. 21, 1998

New hemophilia treatment one step closer to market

Dec. 15, 1998

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

Dec. 15, 1998

First launch for Novartis anticoagulant takes place in Germany

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...